Anti-tissue factor monoclonal antibody - Genentech
Alternative Names: ATF; TF FabLatest Information Update: 28 Oct 2003
At a glance
- Originator Genentech
- Class Monoclonal antibodies
- Mechanism of Action Tissue factor-factor VIIa complex inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Acute coronary syndromes
Most Recent Events
- 08 Oct 2003 Discontinued - Phase-I for Acute coronary syndromes in USA (unspecified route)
- 21 Oct 2002 Phase-I clinical trials in Acute coronary syndromes in USA (unspecified route)
- 04 Jul 2002 Preclinical trials in Acute coronary syndromes in USA (unspecified route)